Central nervous system involvement of granulomatosis with polyangiitis: Clinical-radiological presentation distinguishes different outcomes

Rheumatology (United Kingdom)

Volumn 54, Issue 3, 2015, Pages 424-432

  De Luna, Gonzalo ^a,b   Terrier, Benjamin ^a   Kaminsky, Pierre ^c   Le Quellec, Alain ^d   Maurier, François ^e   Solans, Roser ^f   Godmer, Pascal ^g   Costedoat Chalumeau, Nathalie ^a   Seror, Raphaèle ^h   Charles, Pierre ^a   Cohen, Pascal ^a   Puéchal, Xavier ^a   Mouthon, Luc ^a   Guillevin, Loic ^a  

^a université Paris Cité   (France)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

^d MONTPELLIER UNIVERSITY HOSPITAL   (France)

^e Hospital Vall d'Hebron ^*  (France)

^f HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^g CENTRE HOSPITALIER   (France)

^h BICÊTRE HOSPITAL   (France)

Author keywords

ANCA; Central nervous system; Cerebral vasculitis; Granulomatosis with polyangiitis; Pachymeningitis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; PREDNISONE; RITUXIMAB;

ADOLESCENT; ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; CRANIAL NERVE PARALYSIS; DRUG PULSE THERAPY; EAR NOSE THROAT DISEASE; EYE DISEASE; FEMALE; HEADACHE; HUMAN; KIDNEY DISEASE; LUNG DISEASE; LUNG HEMORRHAGE; MAINTENANCE THERAPY; MALE; MOTOR DYSFUNCTION; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; RANKIN SCALE; RETROSPECTIVE STUDY; SENSORY DYSFUNCTION; TREATMENT RESPONSE; WEGENER GRANULOMATOSIS;

EID: 84941624066     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keu336     Document Type: Article

References (46)

1. Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. Lancet 2008;372: 234-45.
2. Berglund G, Eriksson KF, Israelsson B et al. Cardiovascular risk groups and mortality in an urban Swedish male population: the Malmo Preventive Project. J Intern Med 1996;239:489-97.
3. Salvarani C, Crowson CS, O'Fallon WM, Hunder GG, Gabriel SE. Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. Arthritis Rheum 2004;51:264-8.
4. Nordborg E, Nordborg C. Giant cell arteritis: epidemiological clues to its pathogenesis and an update on its treatment. Rheumatology 2003;42:413-21.
5. Salvarani C, Macchioni P, Zizzi F et al. Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy. Arthritis Rheum 1991; 34:351-6.
6. Gonzalez-Gay MA, Miranda-Filloy JA, Lopez-Diaz MJ et al. Giant cell arteritis in northwestern Spain: a 25-year epidemiologic study. Medicine 2007;86:61-8.
7. Chaudhry IA, Shamsi FA, Elzaridi E et al. Epidemiology of giant-cell arteritis in an Arab population: a 22-year study. Br J Ophthalmol 2007;91:715-8.
8. Kobayashi S, Yano T, Matsumoto Y et al. Clinical and epidemiologic analysis of giant cell (temporal) arteritis from a nationwide survey in 1998 in Japan: the first government-supported nationwide survey. Arthritis Rheum 2003;49:594-8.
9. Weyand CM, Hunder NN, Hicok KC, Hunder GG, Goronzy JJ. HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis. Arthritis Rheum 1994;37:514-20.
10. Rauzy O, Fort M, Nourhashemi F et al. Relation between HLA DRB1 alleles and corticosteroid resistance in giant cell arteritis. Ann Rheum Dis 1998;57:380-2.
11. Salvarani C, Boiardi L, Mantovani V et al. HLA-DRB1, DQA1, and DQB1 alleles associated with giant cell arteritis in northern Italy. J Rheumatol 1999;26:2395-9.
12. Larsson K, Mellstrom D, Nordborg E, Oden A, Nordborg E. Early menopause, low body mass index, and smoking are independent risk factors for developing giant cell arteritis. Ann Rheum Dis 2006;65:529-2.
13. Bergstrom U, Jacobsson LT, Nilsson JA, Wirfalt E, Turesson C. Smoking, low formal level of education, alcohol consumption, and the risk of rheumatoid arthritis. Scand J Rheumatol 2013;42:123-30.
14. Karlson EW, Lee IM, Cook NR et al. A retrospective cohort study of cigarette smoking and risk of rheumatoid arthritis in female health professionals. Arthritis Rheum 1999;42: 910-7.
15. Silman AJ, Newman J, MacGregor AJ. Cigarette smoking increases the risk of rheumatoid arthritis. Results from a nationwide study of disease-discordant twins. Arthritis Rheum 1996;39:732-5.
16. Voigt LF, Koepsell TD, Nelson JL, Dugowson CE, Daling JR. Smoking, obesity, alcohol consumption, and the risk of rheumatoid arthritis. Epidemiology 1994;5: 525-32.
17. Symmons DP, Bankhead CR, Harrison BJ et al. Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England. Arthritis Rheum 1997;40:1955-61.
18. Hutchinson D, Shepstone L, Moots R, Lear JT, Lynch MP. Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RA. Ann Rheum Dis 2001;60:223-7.
19. Saag KG, Cerhan JR, Kolluri S et al. Cigarette smoking and rheumatoid arthritis severity. Ann Rheum Dis 1997;56: 463-9.
20. Hernandez Avila M, Liang MH, Willett WC et al. Reproductive factors, smoking, and the risk for rheumatoid arthritis. Epidemiology 1990;1:285-91.
21. Pedersen M, Jacobsen S, Klarlund M, Frisch M. Socioeconomic status and risk of rheumatoid arthritis: a Danish case-control study. J Rheumatol 2006;33: 1069-74.
22. Li X, Sundquist J, Sundquist K. Socioeconomic and occupational risk factors for rheumatoid arthritis: a nationwide study based on hospitalizations in Sweden. J Rheumatol 2008;35:986-91.
23. Bengtsson C, Nordmark B, Klareskog L et al. Socioeconomic status and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study. Ann Rheum Dis 2005;64:1588-94.
24. Pincus T, Callahan LF, Burkhauser RV. Most chronic diseases are reported more frequently by individuals with fewer than 12 years of formal education in the age 18-64 United States population. J Chronic Dis 1987;40: 865-74.
25. Manjer J, Carlsson S, Elmstahl S et al. The Malmo Diet and Cancer Study: representativity, cancer incidence and mortality in participants and non-participants. Eur J Cancer Prev 2001;10:489-99.
26. National Board of Health and Welfare. The National Patient Register. http://www.socialstyrelsen.se/register/halsodataregister/patientregistret/inenglish (30 July 2014, date last accessed).
27. Hunder GG, Bloch DA, Michel BA et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33: 1122-8.
28. World Health Organization. Obesity and overweight. http://www.who.int/mediacentre/factsheets/fs311/en/index.html (7 November 2013, date last accessed).
29. Hoganson DD, Crowson CS, Warrington KJ, Gabriel SE, Matteson EL. Lack of association of high body mass index with risk for developing polymyalgia rheumatica. Int J Rheum Dis 2010;13:e1-5.
30. Kermani TA, Schafer VS, Crowson CS et al. Cancer preceding giant cell arteritis: a case-control study. Arthritis Rheum 2010;62:1763-9.
31. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569-78.
32. Duhaut P, Pinede L, Demolombe-Rague S et al. Giant cell arteritis and cardiovascular risk factors: a multicenter, prospective case-control study. Groupe de Recherche sur l'Arterite a Cellules Geantes. Arthritis Rheum 1998;41: 1960-5.
33. Karlson EW, Mandl LA, Hankinson SE, Grodstein F. Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the Nurses' Health Study. Arthritis Rheum 2004;50:3458-67.
34. Pikwer M, Bergstrom U, Nilsson JA et al. Breast feeding, but not use of oral contraceptives, is associated with a reduced risk of rheumatoid arthritis. Ann Rheum Dis 2009; 68:526-30.
35. Zöller B, Li X, Sundquist J, Sundquist K. Occupational and socio-economic risk factors for giant cell arteritis: a nationwide study based on hospitalizations in Sweden. Scand J Rheumatol 2013;42:487-97.
36. Purohit A, Reed MJ. Regulation of estrogen synthesis in postmenopausal women. Steroids 2002;67:979-83.
37. Bjarnason NH, Christiansen C. The influence of thinness and smoking on bone loss and response to hormone replacement therapy in early postmenopausal women. J Clin Endocrinol Metab 2000;85:590-6.
38. Turgeon JL, Carr MC, Maki PM, Mendelsohn ME, Wise PM. Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: insights from basic science and clinical studies. Endocr Rev 2006;27: 575-605.
39. Ghisletti S, Meda C, Maggi A, Vegeto E. 17b-estradiol inhibits inflammatory gene expression by controlling NF-kB intracellular localization. Mol Cell Biol 2005;25:2957-68.
40. Trayhurn P. Adipocyte biology. Obes Rev 2007;8(Suppl 1): 41-4.
41. Pasquali R, Vicennati V, Gambineri A, Pagotto U. Sexdependent role of glucocorticoids and androgens in the pathophysiology of human obesity. Int J Obes 2008;32: 1764-79.
42. Akbartabartoori M, Lean ME, Hankey CR. Relationships between cigarette smoking, body size and body shape. Int J Obes 2005;29:236-43.
43. Eisen SA, Lyons MJ, Goldberg J, True WR. The impact of cigarette and alcohol consumption on weight and obesity. An analysis of 1911 monozygotic male twin pairs. Arch Intern Med 1993;153:2457-63.
44. Flegal KM, Troiano RP, Pamuk ER, Kuczmarski RJ, Campbell SM. The influence of smoking cessation on the prevalence of overweight in the United States. N Engl J Med 1995;333:1165-70.
45. Hu G, Hu G, Pekkarinen H et al. Comparison of dietary and non-dietary risk factors in overweight and normal-weight Chinese adults. Br J Nutr 2002;88:91-7.
46. Tanko LB, Christiansen C. An update on the antiestrogenic effect of smoking: a literature review with implications for researchers and practitioners. Menopause 2004;11:104-9.